NASDAQ: INMB - INmune Bio, Inc.

六个月盈利: -42.29%
部门: Healthcare

促销时间表 INmune Bio, Inc.

先进的时间表 简单图表
Financial Markets by TradingView

关于公司

INmune Bio, Inc., a clinical-stage immunology company, focuses on reprogramming the patient's innate immune system to treat cancer and neurodegenerative diseases. It intends to develop and commercialize product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation.

更多详情
The company's development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma solid tumor and patients with high-risk myelodysplastic syndrome; INB03 to treat patients with cancers that express MUC4, a mucinous polyglucan on the surface of some epithelial cancer cells that appears to predict resistant to immunotherapy, including women with MUC4 expressing HER2+ breast cancer and other MUC4 resistant cancers; and XPro1595 for the treatment of Alzheimer's disease and Treatment Resistant Depression. It has license agreements with Xencor, Inc.; Immune Ventures, LLC; and University of Pittsburg. The company was incorporated in 2015 and is headquartered in Boca Raton, Florida.
添加到比较列表
添加到观察列表
添加到投资组合
添加价格通知

Выручка 0.0777
EBITDA -0.0108
Число акций ао 0.01798 млрд
P/S 0.7537
P/BV 2.48
EV/EBITDA -4.77
Цена ао 11.88
ISIN US45782T1051
Сайт https://www.inmunebio.com
Валюта usd
IPO date 2019-02-04
Sector Health Care
Industry Biotechnology
Валюта отчета usd
每日价格变化: 0% (4.83)
每周价格变化: -6.03% (5.14)
每月价格变化: -11.54% (5.46)
3个月内价格变化: -43.38% (8.53)
六个月内的价格变化: -42.29% (8.37)
每年价格变化: -34.99% (7.43)
3年内价格变化: -73.17% (18)
5年内价格变化: -21.97% (6.19)
年初以来价格变化: -35.51% (7.49)
所有参数

低估

姓名 意义 年级
P/S 1220.37 1
P/BV 4.96 3
P/E 0 0
EV/EBITDA -5.51 0
全部的: 2.63

效率

姓名 意义 年级
ROA, % -52.64 0
ROE, % -78.68 0
全部的: 0

股息

姓名 意义 年级
Div yield, % 0 0
DSI 0 0
全部的: 0

责任

姓名 意义 年级
Debt/EBITDA -0.3509 10
全部的: 9.8

成长冲动

姓名 意义 年级
盈利能力 Revenue, % -99.8 0
盈利能力 Ebitda, % 175.38 10
盈利能力 EPS, % 87.52 9
全部的: 7.8
更多详情

机构 体积 分享, %
Vanguard Group Inc 541329 3
Blackrock Inc. 257929 1.43
Rhenman & Partners Asset Management AB 178284 0.99
Geode Capital Management, LLC 170040 0.94
Janney Montgomery Scott LLC 163559 0.91
Deutsche Bank Aktiengesellschaft 109848 0.61
MAI Capital Management 98012 0.54
Quadrant Capital Group LLC 60000 0.33
Royal Bank of Canada 57791 0.32
State Street Corporation 45063 0.25

ETF 分享, % 本年盈利能力, % 股息, %
Avantis U.S Small Cap Equity ETF 0.00028 27.774101036841 1.68271
ProShares Hedge Replication ETF 0.00039 5.9237999659878 1.47892
iShares Micro-Cap ETF 0.01798 36.318555985322 1.54048
iShares Russell 2000 Growth ETF 0.0057 38.042556988 0.6026
ProShares UltraPro Russell2000 0.00138 89.821266282945 1.47873
Vanguard Russell 3000 ETF 0 31.87314172448 1.43817
Vanguard Russell 2000 Growth ETF 0.01 39.350070246167 0.60264
Vanguard Russell 2000 ETF 0 35.648084105685 1.48801



导师 职称 支付 出生年份
Dr. Raymond Joseph Tesi M.D. Co-Founder, President, CEO, Chief Medical Officer & Chairman 500.5k 1956 (68 年)
Mr. David J. Moss M.B.A. CFO, Treasurer & Secretary 394.9k 1970 (54 年)
Dr. Mark William Lowdell BSc, FRCPath, MICR, MSc, Ph.D. Chief Scientific Officer & Chief Manufacturing Officer 150.24k 1963 (61 年)
Mr. Joshua S. Schoonover Esq. General Counsel N/A

地址: United States, Boca Raton. FL, 225 NE Mizner Blvd. - 在 Google 地图中打开, 打开 Yandex 地图
网站: https://www.inmunebio.com